The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future)

Journal of Gastroenterology

Volumn 43, Issue 1, 2008, Pages 18-26

  Ishizaki, Yoichi ^a   Kawasaki, Seiji ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Liver allocation; Liver resection; Liver transplantation; Tumor selection criteria

Indexed keywords

ALCOHOL;

ANAMNESIS; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CHEMOEMBOLIZATION; CHRONIC LIVER DISEASE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT INDICATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 40149093573     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2141-x     Document Type: Review

References (59)

1. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with hepatocellular carcinoma detected during surveillance. Gastroenterology 2004;126:1005-14.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996;334:693-9.
3. Ringe B Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-85.
4. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 1993;218:145-51.
5. Stone MJ, Fulmer JM, Klintmalm GB. Transplantation for primary hepatic malignancy. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Second Ed. Philadelphia: Saunders; 2005. p. 211-32.
6. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311-22.
7. Ravaioli M, Ercolani G, Cescon M, Vetrone G, Voci C, Grigioni WF, et al. Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria. Liver Transpl 2004;10:1195-202.
8. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999;30:1434-40.
9. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, et al. Transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004;10:911-8.
10. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005;40:225-35.
11. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329-35.
12. United Network for Organ Sharing. About the MELD/PELD calculator. http://www.unos.org/resources/MeldPeldCalculator.asp?index=97. Accessed: 19 October 2007.
13. Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, et al. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol 2006;41:1005-10.
14. United Network for Organ Sharing. Policy 3.6 organ distribution: allocation of livers. Revised December 14, 2006. http://www.unos.org/ policiesandbylaws/policies.asp?resources=true. Accessed: 19 October 2007.
15. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 2004;10:36-41.
16. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
17. Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transpl 2006;6:1957-62.
18. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology 2001;33:1073-9.
19. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation. A prospective study. Ann Surg 2004;240:900-9.
20. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557-63.
21. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of preoperative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005;5:795-804.
22. Lesurtel M, Mullhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge of liver transplantation for hepatocellular carcinoma: An evidence-based analysis. Am J Transpl 2006;6:2644-50.
23. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, et al. Resection prior to liver resection for hepatocellular carcinoma. Ann Surg 2003;238:885-93.
24. Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007;13:741-6.
25. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis. Ann Surg 2003;238:508-19.
26. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients; outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580-7.
27. Shabahang M, Franceschi D, Yamashiki N, Reddy R, Pappas PA, Aviles K, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002;9:881-6.
28. Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005;11:1242-51.
29. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003;9:513-20.
30. Cillo U, Vitale A, Brolese A, Zanus G, Neri D, Valmasoni M, et al. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. J Surg Oncol 2007;95:213-20.
31. Ishizaki Y, Yoshimoto J, Sugo H, Miwa K, Kawasaki S. Hepatectomy using the traditional Péan clamp crushing technique under intermittent Pringle maneuver. Am J Surg 2008 (in press).
32. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantations. Ann Surg 2002;235:373-82.
33. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg 1998;227:269-74.
34. Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for nonresectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis. Transplantation 2001;72:861-8.
35. Kawasaki S. Living-donor liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 2002;49:53-5.
36. Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan. Ann Surg 2004;240:451-61.
37. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005;11:1265-72.
38. Takada Y, Ueda M, Ito T, Sakamoto S, et al. Living donor liver transplantation as a second line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006;12:912-9.
39. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-9.
40. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P, et al. Living donor liver transplantation - adult donor outcomes: A systematic review. Liver Transpl 2006;12:24-30.
41. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007;7:2587-94.
42. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502-11.
43. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127:S268-76.
44. Tamura S, Sugawara Y, Kaneko J, Kishi Y, Akamatsu N, Yamashita N, et al. Live donor liver transplantation for hepatocellular carcinoma (abstract 832). Am J Transplant 2006;6(Suppl 2):348.
45. Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127:S277-82.
46. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-94.
47. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-9.
48. Neumaier M, Gerhard M, Wagener C. Diagnosis of micrometastasis by amplification of tissue-specific genes. Gene 1995;159:43-7.
49. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastasis and circulating tumor cells. Cancer 1996;78:10-6.
50. Hillaire S, Barbu V, Boucher E, Moukhar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994;106:239-42.
51. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver. Hepatology 1997;25:564-8.
52. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995;75:2214-9.
53. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study. Hepatology 2002;35:853-60.
54. Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, et al. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation. Transpl Int 2007;20:576-82.
55. Jiang SY, Shyu RY, Huang MF, Tang HS, Young TH, Roffler SR, et al. Detection of alpha-fetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer 1997;75:928-33.
56. Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, et al. Prospective evaluation of circulating hepatocytes by alphafetoprotein mRNA in humans during liver surgery. Ann Surg 1997;226:43-50.
57. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994;73:2464-71.
58. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma. A prospective analysis of 227 patients. Cancer 2001;91:561-9.
59. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma. With special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007;95:235-40.